Hype or Hope? Red Light Therapy for HIE or CP
December 23rd, 2025 | News
| Research
If you’re a parent of a child with HIE or cerebral palsy, you’ve likely seen glowing claims about photobiomodulation or red light therapy—TikTok videos, private social media groups, alternative providers, or companies promising it can “heal brain injury,” “reverse CP,” or “repair neurons.”
It’s tempting. Parents want options, progress, and real hope.
Families deserve evidence, not expensive interventions with no safety or efficacy background. So let’s break down what the science and data actually tells us.
What Is Red Light Therapy?
Red light therapy (RLT) or “photobiomodulation” delivers red or near-infrared wavelengths to tissue in an effort to reduce inflammation or boost cellular energy. There is evidence for benefits in wound healing, dermatology, and joint pain.
But when it comes to treating the human brain, especially in babies and children?
That’s where scientific reality and marketing part ways.
🧠 Can Red Light Therapy Reach the Brain?
Short answer: No—not in a clinically meaningful way.
Here’s what the peer-reviewed research shows:
1. The skull blocks most light.
Across multiple dosimetry and imaging studies, over 90% of red/NIR light is absorbed or scattered by the scalp, skull, and meninges before ever reaching brain tissue.
- Only 1–5% of light reaches the very outer surface of the cortex.
- Brain regions injured in HIE (basal ganglia, thalamus, deep white matter) are far beyond the depth light can reach.
2. Light energy drops off steeply with depth.
Even the small amount that gets through loses power almost immediately—below the threshold needed to affect cells.
3. Positive results in animal studies don’t reflect real human skull thickness.
Many experiments use:
- Open-skull rodent models
- Direct illumination on exposed brain tissue
- Energy levels far higher than consumer devices
None of these conditions match a baby’s or child’s intact skull.
4. No pediatric human clinical trials exist.
There are zero trials in:
- HIE
- Cerebral palsy
- Pediatric epilepsy
- Neonatal brain injury of any type
Promoters often cite rodent studies or adult cognitive studies and then market directly to desperate families. This is not science—it’s salesmanship.
🚩 The Hype Problem: Who Is Selling This?
A critical fact missing from online narratives:
People promoting red light therapy for HIE or CP are not experts in pediatric neurology or brain injury.
They are not:
- Board-certified pediatric neurologists
- Neonatologists
- Neuroscientists
- Clinical trial researchers
- Experts in photobiomodulation dosing or safety
They are:
- Sellers of expensive devices
- Influencers earning affiliate commissions
- Alternative therapy clinics seeking cash-pay clientele
- Individuals misinterpreting rodent experiments as human data
Some claim “FDA approval,” which is misleading. The FDA has not approved red light therapy for brain injury, HIE, CP, neurodevelopmental recovery, or any pediatric neurological condition.
Families deserve to know when marketing is disguised as medical advice.
🌱 But Is There Any Hope for the Future for this?
Science is always evolving. Researchers are exploring photobiomodulation:
- on mitochondrial function
- on inflammatory pathways
- on neuroplasticity (mostly in animals)
But right now, we do not have evidence that:
- red light reaches damaged brain regions
- it produces clinical benefit for motor function, cognition, seizures, or development
- it is safe for long-term use in infants and children
- home devices deliver therapeutic doses at all
Promising concepts do not equal effective treatments.
❤️ What Actually Helps Children with HIE and CP?
Unlike red light therapy, these interventions are backed by decades of rigorous research:
- Early intervention (PT, OT, speech, feeding)
- Spasticity management with known safety profiles
- Adaptive equipment and mobility supports
- Evidence-based seizure management
- Functional vision, cortical visual impairment supports
- Developmental, educational, and behavioral therapies
- Mental health and caregiver support
- Participation in regulated clinical trials
These may not have the flashy appeal of “miracle claims,” but they produce real, measurable progress over time.
⭐ Bottom Line
Red light therapy is currently hype—not evidence-based hope—for children with HIE or cerebral palsy.
- It cannot meaningfully reach or treat deep brain structures affected in HIE.
- No pediatric clinical trials support its use.
- All claims of healing, reversing CP, or repairing neurons lack scientific evidence.
- Those selling it are not pediatric neurologists or brain injury experts.
- Families deserve protection from misleading, costly, unproven therapies.
If stronger evidence emerges in the future, we will welcome it—but right now, the science available is clear that the technology is not capable of the marketing claims.
📚 References: Published Literature Supporting This Summary
Penetration, Physics, and Dosimetry
- Tedford CE et al. Quantitative analysis of transcranial and intraparenchymal light penetration in human cadaver brain tissue. Lasers Surg Med. 2015.
- Henderson TA, Morries LD. Origin of the claim that near-infrared light penetrates the human skull. Photomed Laser Surg. 2021.
- Jagdeo JR et al. Transcranial red and near infrared light: Implications for penetration, absorption, and photobiomodulation. Photochem Photobiol. 2012.
- Moro C et al. Photobiomodulation mechanisms and dosimetry for the brain: A comprehensive review. Photobiomodul Photomed Laser Surg. 2022.
- Lapchak PA, Wu AC. Limitations of photobiomodulation for deep brain structures: A critical analysis. Brain Res. 2023.
Human Studies (Adults Only—Not Pediatric)
- Hamblin MR. Photobiomodulation for brain disorders: A systematic review of human studies. Neurosci Biobehav Rev. 2016.
- Salehpour F et al. Transcranial photobiomodulation therapy for cognitive impairments: A review of clinical trials. J Photochem Photobiol B. 2019.
Animal Studies in Hypoxic-Ischemic Encephalopathy
- Xuan W et al. Low-level laser therapy improves outcomes in a neonatal rat model of hypoxic-ischemic brain injury. J Neurosci Res. 2015.
- Purushothuman S et al. Prenatal photobiomodulation reduces the severity of hypoxic-ischemic injury in neonatal rats. Neuroscience. 2014.
Safety, Efficacy, and Limitations
- Albarracín R et al. Challenges in translating photobiomodulation from animal models to humans. Photobiomodul Photomed Laser Surg. 2020.
- Cassano P et al. Transcranial photobiomodulation: Strengths, limitations, and future directions. Biol Psychiatry. 2020.
